Beyond tissue.
Beyond mechanical.
Beyond long lasting.
BEYOND COMPARE.
TRIA™ heart valves are investigational and not available for sale.
Key advantages of TRIATM Heart valves
- Combines LifePolymer™—an advanced biopolymer—and a patented design to develop long-lasting heart valves without using animal tissue
- Developed to replace diseased heart valves via transcatheter or surgical delivery
- Designed to reduce or eliminate the need for a lifetime of anticoagulant drugs, including their risks and side effects
- Engineered to optimize hemodynamics and effective orifice areas
- Robotically manufactured for a high level of precision
Patient Stories
Bob Murley, the first patient to receive a TRIA aortic heart valve, celebrates his two year anniversary!
See how Bob’s life has changed thanks to the TRIA heart valve.Oregon
See how Bob’s life has changed as he celebrates two year’s with TRIA
Learn about Bob’s first year with the TRIA aortic heart valve
“Since I’ve had this valve replacement, I’ve been able to do things that I wasn’t able to do before I had the valve replacement. Its been nine months since my procedure and my daily lifestyle and life has pretty much gotten back to normal. Everything that I used enjoy is pretty much back where it use to be.”
LifePolymerTM –
A Material Difference
- Formulated for enhanced durability
- Thin leaflet material applicable to low TAVR profile
- Animal studies show no calcification or pannus formation
- No animal supply or potential BSE contamination issues1
- Robotic manufacturing for high volume/low overhead production
CHRONIC SHEEP STUDY
DESIGNED TO LAST A LIFETIME
- FEA designed – tailored to unique stresses of aortic and mitral positions
- TAVR valve designed to reduce profile without compromising durability
- Designed to optimize EOA and hemodynamics
- Engineered to resist leaflet damage propagation
AUTOMATED MANUFACTURING – A PARADIGM SHIFT
- Computer controlled, high volume manufacturing process increases output and decreases labor requirements
- Robotically assisted manufacturing process provides high quality precision
- High volume capacity and reduced labor needs result in lower per valve cost
LEARN HOW FOLDAX IS TRANSFORMING
HEART VALVE THERAPY
First Patients Outside of U.S. Treated with TRIA™ Polymer Surgical Mitral Heart Valve
Review Article: Polymer prosthetic heart valves: A review of current technologies and future directions
CRT23: TRIA TAVR Validation of Design in Chronic Ovine Model